title: Long-term survival of syngeneic islet grafts in BCG-treated diabetic NOD mice can be reversed by cyclophosphamide.
authors.affiliation: Department of Surgery, University of Alberta, Edmonton, Canada.
authors.forename: J R
authors.initials: JR
authors.lastname: Lakey
authors.forename: B
authors.initials: B
authors.lastname: Singh
authors.forename: G L
authors.initials: GL
authors.lastname: Warnock
authors.forename: J F
authors.initials: JF
authors.lastname: Elliott
authors.forename: R V
authors.initials: RV
authors.lastname: Rajotte
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000633:toxicity*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D005260:Female; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013997:Time Factors
chemical_list: D001500:BCG Vaccine; D003520:Cyclophosphamide